Original Research
Published on 29 Aug 2024
Bispecific killer cell engagers employing species cross-reactive NKG2D binders redirect human and murine lymphocytes to ErbB2/HER2-positive malignancies
in Cancer Immunity and Immunotherapy
![Bispecific killer cell engagers employing species cross-reactive NKG2D binders redirect human and murine lymphocytes to ErbB2/HER2-positive malignancies](https://www.frontiersin.org/files/myhome article library/1457887/1457887_Thumb_400.jpg)
- 344 views
Original Research
Published on 29 Aug 2024
in Cancer Immunity and Immunotherapy
Perspective
Published on 29 Aug 2024
in Computational Methods in Chemical Engineering
Original Research
Published on 29 Aug 2024
in Drugs Outcomes Research and Policies
Original Research
Published on 29 Aug 2024
in Marine Affairs and Policy
Review
Published on 29 Aug 2024
in Cellular and Molecular Mechanisms of Brain-aging
Original Research
Published on 29 Aug 2024
in Microbiological Chemistry and Geomicrobiology
Original Research
Published on 29 Aug 2024
in Dermatology
Original Research
Published on 29 Aug 2024
in Public Mental Health
Original Research
Published on 29 Aug 2024
in Inflammation Pharmacology
Original Research
Published on 29 Aug 2024
in Addictive Behaviors
Original Research
Published on 29 Aug 2024
in Alzheimer's Disease and Related Dementias
Original Research
Published on 29 Aug 2024
in Environmental Health and Exposome
Original Research
Published on 29 Aug 2024
in Cardiac Rhythmology
Original Research
Published on 29 Aug 2024
in Genitourinary Oncology
Original Research
Published on 29 Aug 2024
in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers
Original Research
Published on 29 Aug 2024
in Orthopedic Surgery